Lion Point Capital, LP

CIK

1643354

Location

NEW YORK, NY

Portfolio Value

Micro $16,732,088

Diversification

Diversified

Filing Date

Global Rank

#7,872 / 8,623 ▲ 10 · as of Mar 2026

Top Industry

Biotechnology 89.6%

3Y Alpha vs SPY

+14.2%

Period ended 4 months ago

Filed May 15, 2026 · 3mo

25 quarters · since Mar 2020

Clone Performance

Jul 2023–Jul 2026 · vs SPY

Hypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.

Not a measure of this manager's performance. Most of Lion Point Capital, LP's reported book is option positions, which a stock-only clone cannot replicate. The figures below are the return of the 80% that is ordinary stock — as little as 26% in one quarter — so a manager whose options thesis lost money can still show a large gain here.

Cloned portfolio

+131.0%

SPY

+65.3%

Annualised alpha

+14.0%

Max drawdown

−39.5%

Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 80% of reported value on average across 13 quarters. Past performance does not predict future results.

Portfolio Concentration

35 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025

Top Position

8.6%

+0.5 pts

Top 5

33.2%

+4.5 pts

Top 10

54.6%

+5.1 pts

HHI

416

Diversified+41

Portfolio Trend

25 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2026

Sector	% Portfolio	Value	Positions
Healthcare	100.0%	$16,732,088	35

Last Quarter's Activity

Export CSV

Mar 31, 2026 vs Dec 31, 2025

Added To

Positions the filer increased

3 positions

Ticker	Company	Δ Shares	Shares	Value
HUMA	Humacyte, Inc.	+150,000	650,000	$394,550
MIST	Milestone Pharmaceuticals Inc.	+65,000	820,000	$975,800
CMPS	COMPASS Pathways plc	+22,000	80,000	$442,400
No positions match the current search.

Trimmed

Positions the filer reduced

No qualifying positions this quarter.

New Positions

Positions the filer opened this quarter

No qualifying positions this quarter.

Sold Out

Positions the filer fully exited

2 positions

Ticker	Company	Shares	Value
DAWN	Day One Biopharmaceuticals, Inc.	42,000	$391,440
NERV	Minerva Neurosciences, Inc.	35,000	$140,700
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

35 tracked positions · $16,732,088 total · filing declares 35 positions · $16,731,769 · as of Mar 31, 2026

All sectors Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	% of Portfolio
PRAX	Praxis Precision Medicines, Inc. Healthcare	Held	4,450	0	$1,433,745	+9.3%	8.57%
MLTX	MoonLake Immunotherapeutics Healthcare	Held	67,500	0	$1,258,200	+41.4%	7.52%
RPRX	Royalty Pharma plc Healthcare	Held	21,400	0	$1,026,558	+24.1%	6.14%
MIST	Milestone Pharmaceuticals Inc. Healthcare	Added	820,000	+65,000	$975,800	−36.0%	5.83%
GERN	Geron Corp Healthcare	Held	578,000	0	$861,220	+12.9%	5.15%
SNDX	Syndax Pharmaceuticals Inc Healthcare	Held	36,000	0	$840,960	+11.2%	5.03%
ARDX	Ardelyx, Inc. Healthcare	Held	128,650	0	$770,613	+2.7%	4.61%
FENC	Fennec Pharmaceuticals Inc. Healthcare	Held	112,434	0	$691,469	−20.1%	4.13%
BNTC	Benitec Biopharma Inc. Healthcare	Held	62,000	0	$660,300	−20.9%	3.95%
SRPT	Sarepta Therapeutics, Inc. Healthcare	Held	28,500	0	$620,160	+1.1%	3.71%
IRON	Disc Medicine, Inc. Healthcare	Held	8,100	0	$517,914	−19.5%	3.10%
CUE	Cue Biopharma, Inc. Healthcare	Held	2,202,854	0	$506,656	−24.6%	3.03%
CMPS	COMPASS Pathways plc Healthcare	Added	80,000	+22,000	$442,400	+10.5%	2.64%
BHVN	Biohaven Ltd. Healthcare	Held	51,700	0	$437,382	−25.1%	2.61%
LNTH	Lantheus Holdings, Inc. Healthcare	Held	5,500	0	$417,175	+14.0%	2.49%
JSPR	Jasper Therapeutics, Inc. Healthcare	Held	465,000	0	$407,340	−52.1%	2.43%
HUMA	Humacyte, Inc. Healthcare	Added	650,000	+150,000	$394,550	−17.9%	2.36%
VTRS	Viatris Inc Healthcare	Held	27,700	0	$374,227	+8.5%	2.24%
KURA	Kura Oncology, Inc. Healthcare	Held	46,000	0	$373,980	−21.8%	2.24%
BBIO	BridgeBio Pharma, Inc. Healthcare	Held	5,000	0	$371,300	−2.9%	2.22%
DYN	Dyne Therapeutics, Inc. Healthcare	Held	18,000	0	$326,340	−7.3%	1.95%
RCKT	Rocket Pharmaceuticals, Inc. Healthcare	Held	86,000	0	$307,880	+2.0%	1.84%
PCRX	Pacira BioSciences, Inc. Healthcare	Held	13,500	0	$305,100	−12.7%	1.82%
EWTX	Edgewise Therapeutics, Inc. Healthcare	Held	9,100	0	$286,650	+26.9%	1.71%
MLYS	Mineralys Therapeutics, Inc. Healthcare	Held	10,500	0	$284,445	−25.4%	1.70%
MCRB	Seres Therapeutics, Inc. Healthcare	Held	31,570	0	$280,025	−40.4%	1.67%
JANX	Janux Therapeutics, Inc. Healthcare	Held	19,000	0	$264,100	+0.7%	1.58%
QURE	uniQure N.V. Healthcare	Held	14,700	0	$240,345	−31.7%	1.44%
RGNX	REGENXBIO Inc. Healthcare	Held	26,600	0	$222,908	−41.8%	1.33%
AZTA	Azenta, Inc. Healthcare	Held	9,700	0	$204,961	−36.5%	1.22%
INVA	Innoviva, Inc. Healthcare	Held	8,200	0	$191,060	+16.6%	1.14%
GHRS	GH Research PLC Healthcare	Held	10,200	0	$143,412	+10.7%	0.86%
ARQT	Arcutis Biotherapeutics, Inc. Healthcare	Held	5,250	0	$123,690	−18.9%	0.74%
IPHA	Innate Pharma SA Healthcare	Held	81,151	0	$103,873	−26.9%	0.62%
SPRB	Spruce Biosciences, Inc. Healthcare	Held	1,000	0	$65,350	−25.0%	0.39%

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.